Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Aug 12, 2024, after the close
10-Q filed Aug 12, 2024, 43 days after period end · 0000320017-24-000051
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | — |
| Net Income | -$5.04M | -$4.03M | -$6.63M | -$5.68M |
| EPS Diluted |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.61 |
| -$0.50 |
| -$1.64 |
| -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
